Charles River Launches Validated Digital Microscope

Leading the Way in Digital Pathology

Charles River is now the first non-clinical pathology group in the world with a fully GLP validated Deciphex Patholytix digital microscope for completing primary and peer-review pathology evaluations for toxicology studies.

We have completed the GLP validation process for all Patholytix-enabled sites and the entire “pixel pathway” is ready for use.

"This has been a long journey starting with the work and vision of groundbreaking colleagues from Pathology, IT, QA, and Computer System Validation and our partners at Deciphex. The multi-year project included testing and qualification of the hardware, new automation initiatives for the scanning and uploading process, and the kick-off of a ‘cloud-first’ project with IT for storing/archiving digital images. As a leading non-clinical CRO, we will be nimbler and more flexible in Pathology and can apply artificial intelligence tools that will support both quality and automation.”

- Dan Rudmann, Scientific Director, Digital Pathology

We recently completed our first fully digital GLP study (primary and peer-review) for a mid-sized pharmaceutical company who needed to meet accelerated timelines in support of their clinical development plan. By using our pathologists from Australia, and Denver, Colorado, we were able to deliver a peer-reviewed pathology report approximately one month earlier than with site-based pathologists using glass slides.

Learn more about our digital pathology journey and how we can support you.

Discuss Your Digital Pathology Needs